All AbMole products are for research use only, cannot be used for human consumption.
Deferiprone is the only orally active iron-chelating agent with an affinity for ferric ion (iron III)，binds with ferric ions to form neutral 3:1 (deferiprone:iron) complexes that are stable over a wide range of pH values. Deferiprone is used therapeutically in conditions of transfusional iron overload.
biochemistry and molecular biology. 2024 May.
MDH2 Promotes Hepatocellular Carcinoma Growth through Ferroptosis Evasion via Stabilizing GPX4
Deferiprone purchased from AbMole
| Molecular Weight | 139.15 |
| Formula | C7H9NO2 |
| CAS Number | 30652-11-0 |
| Solubility (25°C) | DMSO 6 mg/mL Water 3 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[2] Robert C Hider, et al. The Role of Deferiprone in Iron Chelation
[3] Ami Belmont, et al. Deferiprone for the treatment of transfusional iron overload in thalassemia
[4] Sheila A Fisher, et al. Oral deferiprone for iron chelation in people with thalassaemia
| Related Ferroptosis Products |
|---|
| HBED
HBED is a potent iron chelator. |
| viFSP1
viFSP1 is a species-independent inhibitor of FSP1 that induces ferroptosis in FSP1-dependent cells. |
| icFSP1
icFSP1 is a potent ferroptosis suppressor protein-1 (FSP1) inhibitor. |
| (R)-HTS-3
(R)-HTS-3 is an lysophosphatidylcholine acyltransferase 3 (LPCAT3) inhibitor, with an IC50 of 0.09 μM. |
| CuATSP
CuATSP is a potent inhibitor of ferroptosis. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
